Color

Genomic Testing Company

Approximate capitalization

$4.6 B

Foundation year

2013

Pre-IPO

Current offer

Placement price Available after authorization

Minimum investment Available after authorization

Available volume Available after authorization

Make a request

About

Total Funding

$416M

Color is a population health technology company that aims to enable the delivery of advanced healthcare through clinical genetics. Color’s Population Genomics Platform offers modular and end-to-end solutions that enable organizations to effectively build and scale population health programs. A select list of Color’s partners includes NorthShore University Health System, the National Institutes of Health (NIH), Ochsner Health System, Verily, Apple, Visa, Levi Strauss, and Salesforce.

Color launched its first product in 2015 and is based in Burlingame, California. Notable investors include T. Rowe Price, Viking Global Investors, and General Catalyst.

Number of employees

501 - 1000

Headquarters

Burlingame CA, US

Investors

CRV

DoorDash, Bird, Twitter, ClassPass, Recursion Pharmaceuticals, Niantic, Airtable, Simplivity, Patreon, Oportun

Emerson Collective

Udacity, The Athletic, Color, Boom Supersonic, Revolution Foods

General Catalyst Partners

Snap, Jet, Stripe, Oscar Health, Vroom, Deliveroo, Samsara, Circle, Getaround, ClassPass

LeFrak

Blink Health, Color

LionTree Partners

Color, Splice

Pegasus Tech Ventures

Color, App Annie, Lark

Shasta Ventures

Dollar Shave Club, Turo, Nextdoor, Anaplan, Zuora, Smule, Bill.com, Doctor On Demand, Color, Lithium

T. Rowe Price

WeWork, Cruise, Airbnb, Rivian, Magic Leap, Vroom, Ginkgo Bioworks, Deliveroo, Pure Storage, LivingSocial

Viking Global Investors

Impossible Foods, Moderna Therapeutics, Ginkgo Bioworks, Adaptive Biotechnologies, Apeel Sciences, Talkdesk, Druva, Credit Karma, PROCEPT BioRobotics, Color